首页> 外文期刊>Journal of Hainan Medical University >Effect of adjuvant salvia miltiorrhiza and ligustrazine therapy on renal function, renal blood perfusion as well as CTGF and TGF-β1 content in patients with chronic renal failure
【24h】

Effect of adjuvant salvia miltiorrhiza and ligustrazine therapy on renal function, renal blood perfusion as well as CTGF and TGF-β1 content in patients with chronic renal failure

机译:丹参和川gust嗪辅助治疗对慢性肾衰竭患者肾功能,肾血流以及CTGF和TGF-β1含量的影响

获取原文
           

摘要

Objective: To analyze the effect of adjuvant salvia miltiorrhiza and ligustrazine therapy onrenal function, renal blood perfusion as well as connective tissue growth factor (CTGF) andtransforming growth factor (TGF)-β1 content in patients with chronic renal failure. Methods:80 patients with chronic renal insufficiency treated in our hospital between March 2013 andMarch 2016 were selected for study and randomly divided into observation group (n=40)and control group (n=40). Control group received conventional therapy and observationgroup received conventional + adjuvant salvia miltiorrhiza and ligustrazine therapy. After 3months of treatment, differences in renal function indexes, illness-related indexes, renal bloodperfusion, CTGF and TGF-β1 content, and so on of two groups of patients were determined.Results: After 3 months of treatment, serum urea nitrogen (BUN), serum creatinine (Scr),β2 microglobulin (β2-MG), intermedin (IMD), fibroblast growth factor 23 (FGF23),cystatin C (CysC), CTGF and TGF-β1 content as well as 24 h urine albumin excretion rate(UAER) level in urine of observation group were significantly lower than those of controlgroup (P<0.05) while glomerular filtration rate (GFR) level and serum adiponectin (APN)content were significantly higher than those of control group (P<0.05); renal perfusionparameters renal cortex Tmax (ATc) and medulla Tmax (ATm) levels of observation groupwere significantly lower than those of control group while cortex peak intensity change (ΔAc),medulla peak intensity change (ΔAm) and peak intensity (PI) levels were significantly higherthan those of control group. Conclusions: Adjuvant salvia miltiorrhiza and ligustrazine therapycan effectively control the overall condition of patients with chronic renal failure, and plays apositive role in improving renal function and increasing renal blood perfusion.
机译:目的:分析丹参和川li嗪辅助治疗对慢性肾衰竭患者肾功能,肾血流灌注以及结缔组织生长因子(CTGF)和转化生长因子(TGF)-β1含量的影响。方法:选择2013年3月至2016年3月在我院就诊的80例慢性肾功能不全患者,随机分为观察组(n = 40)和对照组(n = 40)。对照组接受常规治疗,观察组接受常规+辅助丹参和川gust嗪治疗。治疗3个月后,测定两组患者的肾功能指标,疾病相关指标,肾血流灌注,CTGF和TGF-β1含量等差异。结果:治疗3个月后,血清尿素氮(BUN) ),血清肌酐(Scr),β2微球蛋白(β2-MG),中间蛋白(IMD),成纤维细胞生长因子23(FGF23),胱抑素C(CysC),CTGF和TGF-β1含量以及24小时尿白蛋白排泄率观察组尿液中UAER水平明显低于对照组(P <0.05),肾小球滤过率(GFR)水平和血清脂联素(APN)含量明显高于对照组(P <0.05)。观察组的肾灌注参数肾皮质Tmax(ATc)和延髓Tmax(ATm)水平显着低于对照组,而皮质峰强度变化(ΔAc),髓质峰强度变化(ΔAm)和峰强度(PI)水平显着降低。高于对照组。结论:丹参和川gust嗪辅助治疗可有效控制慢性肾功能衰竭患者的整体状况,对改善肾功能和增加肾血流灌注有积极作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号